_id
6919e91b3c536f8df231829b
Ticker
HIK.LSE
Name
Hikma Pharmaceuticals PLC
Exchange
LSE
Address
1 New Burlington Place, London, United Kingdom, W1S 2HR
Country
UK
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
GBX
Website
https://www.hikma.com
Description
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Last Close
15360000
Volume
27789
Current Price
1545
Change
0.9114583333333334
Last Updated
2025-12-30T11:01:49.763Z
Image
https://logo.clearbit.com/www.hikma.com
Ipo Date
-
Market Cap
3401501696
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.986
Sentiment Sources
1
Rating
4.18
Strong Buy
3
Buy
7
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
1658000000
Cost Of Revenue
943000000
Gross Profit
715000000
Operating Expenses
456000000
Operating Income
259000000
Interest Expense
40000000
Pretax Income
295000000
Net Income
238000000
Eps
1.0649087808758275
Dividends Per Share
106000000
Shares Outstanding
221451926
Income Tax Expense
55000000
EBITDA
259000000
Operating Margin
15.621230398069963
Total Other Income Expense Net
36000000
Cash
236000000
Short Term Investments
-
Receivables
1069000000
Inventories
1082000000
Total Current Assets
2557000000
Property Plant Equipment
1373000000
Total Assets
5554000000
Payables
611000000
Short Term Debt
716000000
Long Term Debt
798000000
Total Liabilities
3003000000
Equity
2496000000
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-
Cash From Operations
161000000
Capital Expenditures
68000000
Cash From Investing
-215000000
Cash From Financing
98000000
Net Change In Cash
44000000
Cf_currency_symbol
-
PE
12.3871
PB
138.3402167247596
ROE
9.535256410256409
ROA
4.285199855959668
FCF
93000000
Fcf Percent
0.05609167671893848
Piotroski FScore
3
Health Score
47
Deep Value Investing Score
5
Defensive Investing Score
6
Dividend Investing Score
3.5
Economic Moat Investing Score
7
Garp Investing Score
6
Growth Investing Score
5.5
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
6
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1658000000
Quarters > 0 > income Statement > cost Of Revenue
943000000
Quarters > 0 > income Statement > gross Profit
715000000
Quarters > 0 > income Statement > operating Expenses
456000000
Quarters > 0 > income Statement > operating Income
259000000
Quarters > 0 > income Statement > interest Expense
40000000
Quarters > 0 > income Statement > pretax Income
295000000
Quarters > 0 > income Statement > net Income
238000000
Quarters > 0 > income Statement > eps
1.0649087808758275
Quarters > 0 > income Statement > dividends Per Share
106000000
Quarters > 0 > income Statement > shares Outstanding
223493321
Quarters > 0 > income Statement > income Tax Expense
55000000
Quarters > 0 > income Statement > EBITDA
259000000
Quarters > 0 > income Statement > operating Margin
15.621230398069963
Quarters > 0 > income Statement > total Other Income Expense Net
36000000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
236000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1069000000
Quarters > 0 > balance Sheet > inventories
1082000000
Quarters > 0 > balance Sheet > total Current Assets
2557000000
Quarters > 0 > balance Sheet > property Plant Equipment
1373000000
Quarters > 0 > balance Sheet > total Assets
5554000000
Quarters > 0 > balance Sheet > payables
611000000
Quarters > 0 > balance Sheet > short Term Debt
716000000
Quarters > 0 > balance Sheet > long Term Debt
798000000
Quarters > 0 > balance Sheet > total Liabilities
3003000000
Quarters > 0 > balance Sheet > equity
2496000000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
161000000
Quarters > 0 > cash Flow > capital Expenditures
68000000
Quarters > 0 > cash Flow > cash From Investing
-215000000
Quarters > 0 > cash Flow > cash From Financing
98000000
Quarters > 0 > cash Flow > net Change In Cash
44000000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1.0649087808758275
Quarters > 0 > ratios > PB
138.3402167247596
Quarters > 0 > ratios > ROE
9.535256410256409
Quarters > 0 > ratios > ROA
4.285199855959668
Quarters > 0 > ratios > FCF
93000000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.05609167671893848
Quarters > 0 > health Score
47
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1558000000
Quarters > 1 > income Statement > cost Of Revenue
899000000
Quarters > 1 > income Statement > gross Profit
659000000
Quarters > 1 > income Statement > operating Expenses
398000000
Quarters > 1 > income Statement > operating Income
261000000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
167000000
Quarters > 1 > income Statement > net Income
133000000
Quarters > 1 > income Statement > eps
0.5958133601836998
Quarters > 1 > income Statement > dividends Per Share
71000000
Quarters > 1 > income Statement > shares Outstanding
223224266
Quarters > 1 > income Statement > income Tax Expense
34000000
Quarters > 1 > income Statement > EBITDA
288000000
Quarters > 1 > income Statement > operating Margin
16.752246469833118
Quarters > 1 > income Statement > total Other Income Expense Net
-94000000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
188000000
Quarters > 1 > balance Sheet > short Term Investments
25000000
Quarters > 1 > balance Sheet > receivables
905000000
Quarters > 1 > balance Sheet > inventories
986000000
Quarters > 1 > balance Sheet > total Current Assets
2263000000
Quarters > 1 > balance Sheet > property Plant Equipment
1326000000
Quarters > 1 > balance Sheet > total Assets
5133000000
Quarters > 1 > balance Sheet > payables
358000000
Quarters > 1 > balance Sheet > short Term Debt
653000000
Quarters > 1 > balance Sheet > long Term Debt
607000000
Quarters > 1 > balance Sheet > total Liabilities
2812000000
Quarters > 1 > balance Sheet > equity
2310000000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
133000000
Quarters > 1 > cash Flow > depreciation
95000000
Quarters > 1 > cash Flow > change In Working Capital
10000000
Quarters > 1 > cash Flow > cash From Operations
366000000
Quarters > 1 > cash Flow > capital Expenditures
96000000
Quarters > 1 > cash Flow > cash From Investing
-275000000
Quarters > 1 > cash Flow > cash From Financing
-136000000
Quarters > 1 > cash Flow > net Change In Cash
-236000000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.5958133601836998
Quarters > 1 > ratios > PB
149.29934674025972
Quarters > 1 > ratios > ROE
5.757575757575758
Quarters > 1 > ratios > ROA
2.59107734268459
Quarters > 1 > ratios > FCF
270000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.17329910141206675
Quarters > 1 > health Score
56
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1569000000
Quarters > 2 > income Statement > cost Of Revenue
813000000
Quarters > 2 > income Statement > gross Profit
756000000
Quarters > 2 > income Statement > operating Expenses
405000000
Quarters > 2 > income Statement > operating Income
351000000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
288000000
Quarters > 2 > income Statement > net Income
226000000
Quarters > 2 > income Statement > eps
1.0100000010725663
Quarters > 2 > income Statement > dividends Per Share
104000000
Quarters > 2 > income Statement > shares Outstanding
223762376
Quarters > 2 > income Statement > income Tax Expense
59000000
Quarters > 2 > income Statement > EBITDA
499000000
Quarters > 2 > income Statement > operating Margin
22.37093690248566
Quarters > 2 > income Statement > total Other Income Expense Net
-63000000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
236000000
Quarters > 2 > balance Sheet > short Term Investments
24000000
Quarters > 2 > balance Sheet > receivables
937000000
Quarters > 2 > balance Sheet > inventories
936000000
Quarters > 2 > balance Sheet > total Current Assets
2285000000
Quarters > 2 > balance Sheet > property Plant Equipment
1137000000
Quarters > 2 > balance Sheet > total Assets
4847000000
Quarters > 2 > balance Sheet > payables
541000000
Quarters > 2 > balance Sheet > short Term Debt
215000000
Quarters > 2 > balance Sheet > long Term Debt
1017000000
Quarters > 2 > balance Sheet > total Liabilities
2547000000
Quarters > 2 > balance Sheet > equity
2286000000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
226000000
Quarters > 2 > cash Flow > depreciation
102000000
Quarters > 2 > cash Flow > change In Working Capital
-223000000
Quarters > 2 > cash Flow > cash From Operations
198000000
Quarters > 2 > cash Flow > capital Expenditures
69000000
Quarters > 2 > cash Flow > cash From Investing
-106000000
Quarters > 2 > cash Flow > cash From Financing
-52000000
Quarters > 2 > cash Flow > net Change In Cash
236000000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
1.0100000010725663
Quarters > 2 > ratios > PB
151.23047721784778
Quarters > 2 > ratios > ROE
9.88626421697288
Quarters > 2 > ratios > ROA
4.662677945120693
Quarters > 2 > ratios > FCF
129000000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.08221797323135756
Quarters > 2 > health Score
51
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
1448000000
Quarters > 3 > income Statement > cost Of Revenue
756000000
Quarters > 3 > income Statement > gross Profit
692000000
Quarters > 3 > income Statement > operating Expenses
588000000
Quarters > 3 > income Statement > operating Income
310000000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
79000000
Quarters > 3 > income Statement > net Income
59000000
Quarters > 3 > income Statement > eps
0.2648858816848689
Quarters > 3 > income Statement > dividends Per Share
55000000
Quarters > 3 > income Statement > shares Outstanding
222737428
Quarters > 3 > income Statement > income Tax Expense
18000000
Quarters > 3 > income Statement > EBITDA
345000000
Quarters > 3 > income Statement > operating Margin
21.408839779005525
Quarters > 3 > income Statement > total Other Income Expense Net
-43000000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
205000000
Quarters > 3 > balance Sheet > short Term Investments
24000000
Quarters > 3 > balance Sheet > receivables
789000000
Quarters > 3 > balance Sheet > inventories
891000000
Quarters > 3 > balance Sheet > total Current Assets
2100000000
Quarters > 3 > balance Sheet > property Plant Equipment
1141000000
Quarters > 3 > balance Sheet > total Assets
4680000000
Quarters > 3 > balance Sheet > payables
309000000
Quarters > 3 > balance Sheet > short Term Debt
161000000
Quarters > 3 > balance Sheet > long Term Debt
975000000
Quarters > 3 > balance Sheet > total Liabilities
2471000000
Quarters > 3 > balance Sheet > equity
2198000000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
59000000
Quarters > 3 > cash Flow > depreciation
48000000
Quarters > 3 > cash Flow > change In Working Capital
139000000
Quarters > 3 > cash Flow > cash From Operations
386000000
Quarters > 3 > cash Flow > capital Expenditures
85000000
Quarters > 3 > cash Flow > cash From Investing
-214000000
Quarters > 3 > cash Flow > cash From Financing
-239000000
Quarters > 3 > cash Flow > net Change In Cash
-67000000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.2648858816848689
Quarters > 3 > ratios > PB
156.56475262056415
Quarters > 3 > ratios > ROE
2.684258416742493
Quarters > 3 > ratios > ROA
1.2606837606837606
Quarters > 3 > ratios > FCF
301000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.2078729281767956
Quarters > 3 > health Score
55
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3127000000
Annuals > 0 > income Statement > cost Of Revenue
1712000000
Annuals > 0 > income Statement > gross Profit
1415000000
Annuals > 0 > income Statement > operating Expenses
803000000
Annuals > 0 > income Statement > operating Income
612000000
Annuals > 0 > income Statement > interest Expense
75000000
Annuals > 0 > income Statement > pretax Income
455000000
Annuals > 0 > income Statement > net Income
359000000
Annuals > 0 > income Statement > eps
1.6063119845984122
Annuals > 0 > income Statement > dividends Per Share
175000000
Annuals > 0 > income Statement > shares Outstanding
223493321
Annuals > 0 > income Statement > income Tax Expense
93000000
Annuals > 0 > income Statement > EBITDA
787000000
Annuals > 0 > income Statement > operating Margin
19.571474256475856
Annuals > 0 > income Statement > total Other Income Expense Net
-157000000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
188000000
Annuals > 0 > balance Sheet > short Term Investments
25000000
Annuals > 0 > balance Sheet > receivables
905000000
Annuals > 0 > balance Sheet > inventories
986000000
Annuals > 0 > balance Sheet > total Current Assets
2263000000
Annuals > 0 > balance Sheet > property Plant Equipment
1326000000
Annuals > 0 > balance Sheet > total Assets
5133000000
Annuals > 0 > balance Sheet > payables
358000000
Annuals > 0 > balance Sheet > short Term Debt
653000000
Annuals > 0 > balance Sheet > long Term Debt
607000000
Annuals > 0 > balance Sheet > total Liabilities
2812000000
Annuals > 0 > balance Sheet > equity
2310000000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
359000000
Annuals > 0 > cash Flow > depreciation
197000000
Annuals > 0 > cash Flow > change In Working Capital
-213000000
Annuals > 0 > cash Flow > cash From Operations
564000000
Annuals > 0 > cash Flow > capital Expenditures
165000000
Annuals > 0 > cash Flow > cash From Investing
-381000000
Annuals > 0 > cash Flow > cash From Financing
-188000000
Annuals > 0 > cash Flow > net Change In Cash
-17000000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
1.6063119845984122
Annuals > 0 > ratios > PB
149.18904804415584
Annuals > 0 > ratios > ROE
15.541125541125542
Annuals > 0 > ratios > ROA
6.993960646795247
Annuals > 0 > ratios > FCF
399000000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.12759833706427887
Annuals > 0 > health Score
63
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2875000000
Annuals > 1 > income Statement > cost Of Revenue
1468000000
Annuals > 1 > income Statement > gross Profit
1407000000
Annuals > 1 > income Statement > operating Expenses
1040000000
Annuals > 1 > income Statement > operating Income
367000000
Annuals > 1 > income Statement > interest Expense
90000000
Annuals > 1 > income Statement > pretax Income
281000000
Annuals > 1 > income Statement > net Income
190000000
Annuals > 1 > income Statement > eps
0.8544367441905519
Annuals > 1 > income Statement > dividends Per Share
137000000
Annuals > 1 > income Statement > shares Outstanding
222368714
Annuals > 1 > income Statement > income Tax Expense
89000000
Annuals > 1 > income Statement > EBITDA
791000000
Annuals > 1 > income Statement > operating Margin
12.765217391304349
Annuals > 1 > income Statement > total Other Income Expense Net
-86000000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
205000000
Annuals > 1 > balance Sheet > short Term Investments
24000000
Annuals > 1 > balance Sheet > receivables
789000000
Annuals > 1 > balance Sheet > inventories
891000000
Annuals > 1 > balance Sheet > total Current Assets
2100000000
Annuals > 1 > balance Sheet > property Plant Equipment
1141000000
Annuals > 1 > balance Sheet > total Assets
4680000000
Annuals > 1 > balance Sheet > payables
309000000
Annuals > 1 > balance Sheet > short Term Debt
161000000
Annuals > 1 > balance Sheet > long Term Debt
975000000
Annuals > 1 > balance Sheet > total Liabilities
2471000000
Annuals > 1 > balance Sheet > equity
2198000000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
190000000
Annuals > 1 > cash Flow > depreciation
190000000
Annuals > 1 > cash Flow > change In Working Capital
-8000000
Annuals > 1 > cash Flow > cash From Operations
608000000
Annuals > 1 > cash Flow > capital Expenditures
169000000
Annuals > 1 > cash Flow > cash From Investing
-333000000
Annuals > 1 > cash Flow > cash From Financing
-337000000
Annuals > 1 > cash Flow > net Change In Cash
-65000000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.8544367441905519
Annuals > 1 > ratios > PB
156.00207324294811
Annuals > 1 > ratios > ROE
8.644222020018198
Annuals > 1 > ratios > ROA
4.05982905982906
Annuals > 1 > ratios > FCF
439000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.15269565217391304
Annuals > 1 > health Score
57
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2517000000
Annuals > 2 > income Statement > cost Of Revenue
1252000000
Annuals > 2 > income Statement > gross Profit
1265000000
Annuals > 2 > income Statement > operating Expenses
976000000
Annuals > 2 > income Statement > operating Income
591000000
Annuals > 2 > income Statement > interest Expense
77000000
Annuals > 2 > income Statement > pretax Income
233000000
Annuals > 2 > income Statement > net Income
188000000
Annuals > 2 > income Statement > eps
0.8355555555555556
Annuals > 2 > income Statement > dividends Per Share
125000000
Annuals > 2 > income Statement > shares Outstanding
225000000
Annuals > 2 > income Statement > income Tax Expense
42000000
Annuals > 2 > income Statement > EBITDA
485000000
Annuals > 2 > income Statement > operating Margin
23.480333730631706
Annuals > 2 > income Statement > total Other Income Expense Net
-49000000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
270000000
Annuals > 2 > balance Sheet > short Term Investments
22000000
Annuals > 2 > balance Sheet > receivables
777000000
Annuals > 2 > balance Sheet > inventories
776000000
Annuals > 2 > balance Sheet > total Current Assets
1999000000
Annuals > 2 > balance Sheet > property Plant Equipment
1081000000
Annuals > 2 > balance Sheet > total Assets
4471000000
Annuals > 2 > balance Sheet > payables
291000000
Annuals > 2 > balance Sheet > short Term Debt
148000000
Annuals > 2 > balance Sheet > long Term Debt
1074000000
Annuals > 2 > balance Sheet > total Liabilities
2323000000
Annuals > 2 > balance Sheet > equity
2135000000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
233000000
Annuals > 2 > cash Flow > depreciation
193000000
Annuals > 2 > cash Flow > change In Working Capital
-131000000
Annuals > 2 > cash Flow > cash From Operations
530000000
Annuals > 2 > cash Flow > capital Expenditures
225000000
Annuals > 2 > cash Flow > cash From Investing
-607000000
Annuals > 2 > cash Flow > cash From Financing
-58000000
Annuals > 2 > cash Flow > net Change In Cash
-156000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.8355555555555556
Annuals > 2 > ratios > PB
162.50585480093676
Annuals > 2 > ratios > ROE
8.805620608899298
Annuals > 2 > ratios > ROA
4.204875866696488
Annuals > 2 > ratios > FCF
305000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.12117600317838696
Annuals > 2 > health Score
54
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2553000000
Annuals > 3 > income Statement > cost Of Revenue
1252000000
Annuals > 3 > income Statement > gross Profit
1301000000
Annuals > 3 > income Statement > operating Expenses
715000000
Annuals > 3 > income Statement > operating Income
634000000
Annuals > 3 > income Statement > interest Expense
40718274
Annuals > 3 > income Statement > pretax Income
544000000
Annuals > 3 > income Statement > net Income
421000000
Annuals > 3 > income Statement > eps
1.8068669527896997
Annuals > 3 > income Statement > dividends Per Share
120000000
Annuals > 3 > income Statement > shares Outstanding
233000000
Annuals > 3 > income Statement > income Tax Expense
124000000
Annuals > 3 > income Statement > EBITDA
744000000
Annuals > 3 > income Statement > operating Margin
24.833529181355267
Annuals > 3 > income Statement > total Other Income Expense Net
-38000000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
426000000
Annuals > 3 > balance Sheet > short Term Investments
24000000
Annuals > 3 > balance Sheet > receivables
781000000
Annuals > 3 > balance Sheet > inventories
695000000
Annuals > 3 > balance Sheet > total Current Assets
2094000000
Annuals > 3 > balance Sheet > property Plant Equipment
1146000000
Annuals > 3 > balance Sheet > total Assets
4372000000
Annuals > 3 > balance Sheet > payables
262000000
Annuals > 3 > balance Sheet > short Term Debt
121000000
Annuals > 3 > balance Sheet > long Term Debt
651000000
Annuals > 3 > balance Sheet > total Liabilities
1905000000
Annuals > 3 > balance Sheet > equity
2453000000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
544000000
Annuals > 3 > cash Flow > depreciation
145000000
Annuals > 3 > cash Flow > change In Working Capital
-30000000
Annuals > 3 > cash Flow > cash From Operations
638000000
Annuals > 3 > cash Flow > capital Expenditures
229000000
Annuals > 3 > cash Flow > cash From Investing
-238000000
Annuals > 3 > cash Flow > cash From Financing
-287000000
Annuals > 3 > cash Flow > net Change In Cash
103000000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
1.8068669527896997
Annuals > 3 > ratios > PB
146.46799836934366
Annuals > 3 > ratios > ROE
17.16265796983286
Annuals > 3 > ratios > ROA
9.629460201280878
Annuals > 3 > ratios > FCF
409000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.16020368194281237
Annuals > 3 > health Score
76
Valuation > metrics > PE
12.3871
Valuation > metrics > PB
138.3402167247596
Valuation > final Score
50
Valuation > verdict
2255.7% Overvalued
Profitability > metrics > ROE
9.535256410256409
Profitability > metrics > ROA
9.307782557684787
Profitability > metrics > Net Margin
0.14354644149577805
Profitability > final Score
69
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
1.203125
Risk > metrics > Interest Coverage
6.475
Risk > final Score
56
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.9269027882441598
Liquidity > metrics > Quick Ratio
1.1115297663903543
Liquidity > final Score
98
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
42
Prev Profitabilities > 1
71
Prev Profitabilities > 2
20
Prev Risks > 0
39
Prev Risks > 1
37
Prev Risks > 2
35
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:01:56.183Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
1.07
Earnings History > 1 > eps Estimate
1.21
Earnings History > 1 > eps Difference
-0.14
Earnings History > 1 > surprise Percent
-11.5702
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-19
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.6
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.6
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-02-23
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0.82
Earnings History > 3 > eps Difference
-0.82
Earnings History > 3 > surprise Percent
-100
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-08-04
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0.95
Earnings History > 4 > eps Difference
-0.95
Earnings History > 4 > surprise Percent
-100
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-02-24
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0.98
Earnings History > 5 > eps Difference
-0.98
Earnings History > 5 > surprise Percent
-100
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-08-06
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0.9
Earnings History > 6 > eps Difference
-0.9
Earnings History > 6 > surprise Percent
-100
Earnings History > 7 > period
2020-12-31
Earnings History > 7 > report Date
2021-02-25
Earnings History > 7 > date
2020-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
-1.22
Earnings History > 7 > eps Difference
1.22
Earnings History > 7 > surprise Percent
100
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-08-07
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0.74
Earnings History > 8 > eps Difference
-0.74
Earnings History > 8 > surprise Percent
-100
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-11
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0.71
Earnings History > 9 > eps Difference
-0.71
Earnings History > 9 > surprise Percent
-100
Earnings History > 10 > period
2019-06-30
Earnings History > 10 > report Date
2019-08-09
Earnings History > 10 > date
2019-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0.64
Earnings History > 10 > eps Difference
-0.64
Earnings History > 10 > surprise Percent
-100
Earnings History > 11 > period
2018-12-31
Earnings History > 11 > report Date
2019-03-13
Earnings History > 11 > date
2018-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-08-15
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0.41
Earnings History > 12 > eps Difference
-0.41
Earnings History > 12 > surprise Percent
-100
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-03-14
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-4
Earnings History > 13 > eps Estimate
0.44
Earnings History > 13 > eps Difference
-4.44
Earnings History > 13 > surprise Percent
-1009.0909
Earnings History > 14 > period
2017-06-30
Earnings History > 14 > report Date
2017-08-17
Earnings History > 14 > date
2017-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.29
Earnings History > 14 > eps Estimate
0.44
Earnings History > 14 > eps Difference
-0.15
Earnings History > 14 > surprise Percent
-34.0909
Earnings History > 15 > period
2016-12-31
Earnings History > 15 > report Date
2017-03-15
Earnings History > 15 > date
2016-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.4
Earnings History > 15 > eps Estimate
0.37
Earnings History > 15 > eps Difference
0.03
Earnings History > 15 > surprise Percent
8.1081
Earnings History > 16 > period
2016-06-30
Earnings History > 16 > report Date
2016-08-24
Earnings History > 16 > date
2016-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.25
Earnings History > 16 > eps Estimate
0.23
Earnings History > 16 > eps Difference
0.02
Earnings History > 16 > surprise Percent
8.6957
Earnings History > 17 > period
2015-12-31
Earnings History > 17 > report Date
2016-03-16
Earnings History > 17 > date
2015-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.58
Earnings History > 17 > eps Estimate
0.5
Earnings History > 17 > eps Difference
0.08
Earnings History > 17 > surprise Percent
16
Earnings History > 18 > period
2015-06-30
Earnings History > 18 > report Date
2015-08-19
Earnings History > 18 > date
2015-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0.67
Earnings History > 18 > eps Difference
-0.67
Earnings History > 18 > surprise Percent
-100
Earnings History > 19 > period
2014-12-31
Earnings History > 19 > report Date
2015-03-11
Earnings History > 19 > date
2014-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2014-06-30
Earnings History > 20 > report Date
2014-08-20
Earnings History > 20 > date
2014-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
0.63
Earnings History > 20 > eps Difference
-0.63
Earnings History > 20 > surprise Percent
-100
Earnings History > 21 > period
2013-12-31
Earnings History > 21 > report Date
2014-03-12
Earnings History > 21 > date
2013-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADown 22% with a P/E of 9, is Hikma one of the best passive income picks right now? MSN
Read more →Down 33%, is there a once-in-a-decade opportunity in this FTSE 100 stock? - Yahoo Finance UK
1/20/2026
Down 33%, is there a once-in-a-decade opportunity in this FTSE 100 stock? Yahoo Finance UK
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
3
Buy
7
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Hikma Pharmaceuticals PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
1.07
EPS Estimate
1.21
EPS Difference
-0.14
Surprise Percent
-11.5702%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.